Cell Culture Market: Introduction
According to the report, the global cell culture market was valued at US$ 16.6 Bn in 2020 and is projected to expand at a CAGR of 6.4% from 2021 to 2028. Cell culture is the process of removal of living cells from a plant or animal and growing such cells in an artificial, controlled environment. The trend of adoption of cell culture in the field of pharmaceuticals is gaining momentum.
Manufacturing of biopharmaceuticals involves use of cell culture systems as a unique method of product development, as these products are difficult to produce by conventional pharmaceutical development processes. Research & development in the field of biopharmaceuticals that concentrates on discovery of new therapeutics for rare diseases and new mechanisms of drug actions have increased the scope for cell culture in biologics.
Increase in Demand and Approvals for Biosimilar Products and Other Biologic Therapeutics to Drive Market
One of the most significant phases in the creation of biosimilar/biologic therapeutics is cell culture, which helps to boost efficiency and productivity while lowering manufacturing costs. Increase in demand for biosimilar and other biologics for the treatment of chronic diseases such as cancer and diabetes globally has resulted in rise in demand for efficient and cost-effective products. This increased demand is expected to propel the global cell culture market during the forecast period.
With around 240 biosimilars in development, launches will become more frequent. This is likely to augment the global cell culture market over the next few years.
Instruments Segment to Dominate Market
In terms of product, the global cell culture market has been classified into instruments, media, sera, and reagents. The instruments segment has been split into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. The media segment has been segregated into chemically defined media, classical media, lysogeny broths, protein-free media, serum-free media, and specialty media. The sera segment has been categorized into fetal bovine serum and others. The reagents segment has been divided into albumin, amino acids, attachment factors, growth factors & cytokines, protease inhibitor, thrombin, and others.
The instruments segment dominated the global cell culture market in 2020 and the trend is projected to continue during the forecast period. Increase in use of single-use bioprocessing systems for continuous processing is anticipated to propel the segment during the forecast period.
Pharmaceutical Companies to be Highly Lucrative
Based on end-user, the global cell culture market has been classified into biotechnology companies, pharmaceutical companies, academic institutes, and research institutes. The pharmaceutical companies segment dominated the global cell culture market in 2020. Increase in demand for novel therapeutics such as biosimilars and launch of advanced cell culture products are anticipated to boost the growth of the segment during the forecast period. However, the biotechnological companies segment is expected to expand at a high CAGR from 2021 to 2028. Increase in strategic partnerships and collaborations is likely to drive the segment.
North America to Dominate Global Market
In terms of region, the global cell culture market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cell culture market in 2020, followed by Europe. The dominance of these two regions can be attributed to increase in research activities, mergers & acquisitions, and new players entering the market. North America accounted for a major share of the global cell culture market in 2020, primarily due to high demand for biologics & biosimilars, new product development, and presence of major players.
Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=405
The cell culture market in Asia Pacific is projected to expand at the highest CAGR from 2021 to 2028 due to rise in outsourcing activities and expansion of biopharmaceutical manufacturers. Moreover, low cost of manufacturing in China and India has resulted in the rise in production facilities, attracting pharmaceutical and biotechnological companies from across the world to Asia Pacific.
The global cell culture market is consolidated in terms of number of players. Key players in the global market include Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Lonza Group, Sartorius AG, Becton, Dickinson and Company, Corning, Inc., Eppendorf AG, VWR International, and PromoCell GmbH, among others.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453